Nonclinical services for the development of interventional agents for infectious diseases
Active Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
Southern Research Institute UEI CDZJAJJHJMH5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,354,672
Award facts
- Contract value 100% obligated
- $2,354,672.00 Current and potential, with all options
- Completion date 89% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Birmingham, AL 35205, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,354,672 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $2.35 million to Southern Research Institute for nonclinical services supporting the development of interventional agents for infectious diseases. This contract, awarded on May 19, 2022, with an ultimate completion date of April 30, 2027, operates under a cost-plus-fixed-fee pricing structure and is being performed in Birmingham, Alabama. The award represents a child delivery order under the larger "Nonclinical Services for Development of Interventional Agents" Indefinite Delivery/Indefinite Quantity (IDIQ) master contract vehicle. No set-aside designation was applied to this award, indicating open competition.
Southern Research Institute is a nonprofit research organization with extensive experience supporting NIAID and other federal agencies in infectious disease research, drug discovery, and preclinical testing. The organization holds multiple significant IDV contracts with NIAID and other federal agencies valued at over $350 million collectively, demonstrating established capability in developing preclinical infectious disease models, conducting therapeutic screening, and supporting medical countermeasure development. Under this delivery order, Southern Research will leverage its specialized expertise to provide nonclinical development services that support the advancement of interventional therapeutic candidates addressing infectious disease challenges.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to Southern Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 19, 2022.
How much is contract 75N93022F00001 worth?
The government has obligated $2,354,672 on 75N93022F00001.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93018D00006, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award